Five Prime Therapeutics, Inc. Operating Lease Right-of-Use Assets
Five Prime Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $21.28 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2021-03-22
- 2020-12-31: Operating Lease, Right-of-Use Asset $21.28M.
- 2020-09-30: Operating Lease, Right-of-Use Asset $19.85M.
- 2020-06-30: Operating Lease, Right-of-Use Asset $29.28M.
- 2020-03-31: Operating Lease, Right-of-Use Asset $30.30M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2020-12-31 | $21.28M 10-K · filed 2021-03-22 |
| 2020-09-30 | $19.85M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $29.28M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $30.30M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $30.93M 10-K · filed 2021-03-22 |
| 2019-09-30 | $31.55M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $32.14M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $32.72M 10-Q · filed 2019-05-09 |